Protecting Global Heath Since 1909
Dedicated to protecting and improving public health worldwideProtecting Global Heath Since 1909
Dedicated to protecting and improving public health worldwideA Legacy of Public Health Leadership
Bilthoven Biologicals stands on the shoulders of a rich institutional heritage that began over a century ago with the founding of the Central Laboratory for the State Inspectorate in 1909 - an early precursor to the Rijksinstituut voor Volksgezondheid en Milieu (RIVM), the Dutch National Institute for Public Health and the Environment. This laboratory was established to safeguard public health through better hygiene, clean water, and disease prevention—principles that continue to guide Bilthoven Biologicals today. In the decades that followed, Bilthoven became a hub for vaccine development and production.
The RIVM played a central role in manufacturing vaccines for the Dutch national immunization program, and in 2003, these activities were formalized under the Nederlands Vaccin Instituut (NVI). The NVI inherited the vaccine-producing arm of RIVM and continued to supply critical vaccines for diseases such as polio, diphtheria, and tetanus. It is estimated that over 30% of vaccines produced globally rely on technology developed in Bilthoven - a testament to the site’s enduring contribution to global immunization efforts
We are rooted in a legacy of vaccine development and global knowledge-sharing
A Legacy of Public Health Leadership
Bilthoven Biologicals stands on the shoulders of a rich institutional heritage that began over a century ago with the founding of the Central Laboratory for the State Inspectorate in 1909 - an early precursor to the Rijksinstituut voor Volksgezondheid en Milieu (RIVM), the Dutch National Institute for Public Health and the Environment. This laboratory was established to safeguard public health through better hygiene, clean water, and disease prevention—principles that continue to guide Bilthoven Biologicals today. In the decades that followed, Bilthoven became a hub for vaccine development and production.
The RIVM played a central role in manufacturing vaccines for the Dutch national immunization program, and in 2003, these activities were formalized under the Nederlands Vaccin Instituut (NVI). The NVI inherited the vaccine-producing arm of RIVM and continued to supply critical vaccines for diseases such as polio, diphtheria, and tetanus. It is estimated that over 30% of vaccines produced globally rely on technology developed in Bilthoven - a testament to the site’s enduring contribution to global immunization efforts
We are rooted in a legacy of vaccine development and global knowledge-sharing
A pivotal moment came in 2012, when the Cyrus Poonawalla Group - renowned for its global vaccine leadership through the Serum Institute of India - acquired the vaccine-producing division of NVI. This marked the birth of Bilthoven Biologicals as a private entity, combining Dutch scientific rigor with global reach and manufacturing scale.
Today, Bilthoven Biologicals is a Netherlands-based end-to-end vaccine manufacturer with its facilities at the historic USPB campus in Bilthoven. From its origins in public health stewardship to its current role as a global vaccine manufacturer, Bilthoven Biologicals embodies a legacy of scientific excellence, social responsibility, and global health impact.
At Bilthoven Biologicals, our purpose is clear: to advance global health by delivering high-quality biologicals and vaccines that are accessible to all.
We are committed to reducing the burden of preventable diseases and expanding access to life-saving immunization - every person, everywhere, deserves the opportunity to live a healthy life. Based in the Netherlands, Bilthoven Biologicals is a trusted partner in vaccine manufacturing and delivery. Our expertise spans the development and large-scale production of essential vaccines, including those targeting polio, diphtheria, and tetanus, as well as pioneering immunotherapies for underserved conditions such as bladder cancer. Our portfolio reflects a deep commitment to public health priorities and long-term health system resilience.
We operate at the nexus of science, equity, and impact
Guided by the principles of health equity and universal access to preventative care, we work to ensure our products reach the communities most in need - especially in low-resource settings where the burden of disease is greatest. Our approach is collaborative, our standards uncompromising, and our mission urgent.
For our partners, Bilthoven Biologicals offers proven manufacturing excellence, rigorous quality systems, and seamless access to European and global markets. We collaborate with innovators, governments, NGOs, and international health organizations to deliver scalable, regulatory compliant solutions that support immunization programs worldwide.
For those seeking a career with purpose, Bilthoven Biologicals offers a dynamic and mission driven environment where integrity, and impact converge. Our multidisciplinary teams - spanning development, manufacturing, quality assurance, and logistics - are united by a shared commitment to improving lives through science.
Together, we are shaping a healthier, more equitable future—one vaccine at a time.
Mission
Accelerating access to vaccines. By delivering high‑quality vaccines and supporting reliable, responsible manufacturing, we work to ensure that lifesaving protection reaches the people who need it most.
Vision
A world where protection is not a privilege, but a given. We work towards a world in which access to vaccines is shared equally. Because protection works best when it's shared.
Values
Ownership, deliver, collaborate, positivity and agility - with this mindset we work towards our goals of a healthier world.
At Bilthoven Biologicals, our purpose is clear: to advance global health by delivering high-quality biologicals and vaccines that are accessible to all.
We are committed to reducing the burden of preventable diseases and expanding access to life-saving immunization - every person, everywhere, deserves the opportunity to live a healthy life. Based in the Netherlands, Bilthoven Biologicals is a trusted partner in vaccine manufacturing and delivery. Our expertise spans the development and large-scale production of essential vaccines, including those targeting polio, diphtheria, and tetanus, as well as pioneering immunotherapies for underserved conditions such as bladder cancer. Our portfolio reflects a deep commitment to public health priorities and long-term health system resilience.
We operate at the nexus of science, equity, and impact
Guided by the principles of health equity and universal access to preventative care, we work to ensure our products reach the communities most in need - especially in low-resource settings where the burden of disease is greatest. Our approach is collaborative, our standards uncompromising, and our mission urgent.
For our partners, Bilthoven Biologicals offers proven manufacturing excellence, rigorous quality systems, and seamless access to European and global markets. We collaborate with innovators, governments, NGOs, and international health organizations to deliver scalable, regulatory compliant solutions that support immunization programs worldwide.
For those seeking a career with purpose, Bilthoven Biologicals offers a dynamic and mission driven environment where integrity, and impact converge. Our multidisciplinary teams - spanning development, manufacturing, quality assurance, and logistics - are united by a shared commitment to improving lives through science.
Together, we are shaping a healthier, more equitable future—one vaccine at a time.
Mission
Accelerating access to vaccines. By delivering high‑quality vaccines and supporting reliable, responsible manufacturing, we work to ensure that lifesaving protection reaches the people who need it most.
Vision
A world where protection is not a privilege, but a given. We work towards a world in which access to vaccines is shared equally. Because protection works best when it's shared.
Values
Ownership, deliver, collaborate, positivity and agility - with this mindset we work towards our goals of a healthier world.
At Bilthoven Biologicals, our purpose is clear: to advance global health by delivering high-quality biologicals and vaccines that are accessible to all.
We are committed to reducing the burden of preventable diseases and expanding access to life-saving immunization - every person, everywhere, deserves the opportunity to live a healthy life. Based in the Netherlands, Bilthoven Biologicals is a trusted partner in vaccine manufacturing and delivery. Our expertise spans the development and large-scale production of essential vaccines, including those targeting polio, diphtheria, and tetanus, as well as pioneering immunotherapies for underserved conditions such as bladder cancer. Our portfolio reflects a deep commitment to public health priorities and long-term health system resilience.
We operate at the nexus of science, equity, and impact
Guided by the principles of health equity and universal access to preventative care, we work to ensure our products reach the communities most in need - especially in low-resource settings where the burden of disease is greatest. Our approach is collaborative, our standards uncompromising, and our mission urgent.
For our partners, Bilthoven Biologicals offers proven manufacturing excellence, rigorous quality systems, and seamless access to European and global markets. We collaborate with innovators, governments, NGOs, and international health organizations to deliver scalable, regulatory compliant solutions that support immunization programs worldwide.
For those seeking a career with purpose, Bilthoven Biologicals offers a dynamic and mission driven environment where integrity, and impact converge. Our multidisciplinary teams - spanning development, manufacturing, quality assurance, and logistics - are united by a shared commitment to improving lives through science.
Together, we are shaping a healthier, more equitable future—one vaccine at a time.
Mission
Accelerating access to vaccines. By delivering high‑quality vaccines and supporting reliable, responsible manufacturing, we work to ensure that lifesaving protection reaches the people who need it most.
Vision
A world where protection is not a privilege, but a given. We work towards a world in which access to vaccines is shared equally. Because protection works best when it's shared.
Values
Ownership, deliver, collaborate, positivity and agility - with this mindset we work towards our goals of a healthier world.
At Bilthoven Biologicals, our purpose is clear: to advance global health by delivering high-quality biologicals and vaccines that are accessible to all.
We are committed to reducing the burden of preventable diseases and expanding access to life-saving immunization - every person, everywhere, deserves the opportunity to live a healthy life. Based in the Netherlands, Bilthoven Biologicals is a trusted partner in vaccine manufacturing and delivery. Our expertise spans the development and large-scale production of essential vaccines, including those targeting polio, diphtheria, and tetanus, as well as pioneering immunotherapies for underserved conditions such as bladder cancer. Our portfolio reflects a deep commitment to public health priorities and long-term health system resilience.
We operate at the nexus of science, equity, and impact
Guided by the principles of health equity and universal access to preventative care, we work to ensure our products reach the communities most in need - especially in low-resource settings where the burden of disease is greatest. Our approach is collaborative, our standards uncompromising, and our mission urgent.
For our partners, Bilthoven Biologicals offers proven manufacturing excellence, rigorous quality systems, and seamless access to European and global markets. We collaborate with innovators, governments, NGOs, and international health organizations to deliver scalable, regulatory compliant solutions that support immunization programs worldwide.
For those seeking a career with purpose, Bilthoven Biologicals offers a dynamic and mission driven environment where integrity, and impact converge. Our multidisciplinary teams - spanning development, manufacturing, quality assurance, and logistics - are united by a shared commitment to improving lives through science.
Together, we are shaping a healthier, more equitable future—one vaccine at a time.
Mission
Accelerating access to vaccines. By delivering high‑quality vaccines and supporting reliable, responsible manufacturing, we work to ensure that lifesaving protection reaches the people who need it most.
Vision
A world where protection is not a privilege, but a given. We work towards a world in which access to vaccines is shared equally. Because protection works best when it's shared.
Values
Ownership, deliver, collaborate, positivity and agility - with this mindset we work towards our goals of a healthier world.
Leadership
Jurgen Kwik
Chief Executive Officer
Leading Bilthoven Biologicals global strategy with extensive experience in public health and vaccine innovations.
Leadership
Jurgen Kwik
Chief Executive Officer
Leading Bilthoven Biologicals global strategy with extensive experience in public health and vaccine innovations.
Our worldwide network of facilities and partnerships
Serum Institute of India →
- ·Vaccine R&D
- ·Vaccine production
- ·Worldwide distribution
Bilthoven Biologicals →
- ·Vaccine production
- ·QC testing and releasing
- ·Worldwide distribution
Serum Life Sciences Europe →
- ·Clinical Trial management
- ·Translational project management
Serum Life Sciences UK →
- ·UK Corporate Office
Our worldwide network of facilities and partnerships
Serum Institute of India →
- ·Vaccine R&D
- ·Vaccine production
- ·Worldwide distribution
Bilthoven Biologicals →
- ·Vaccine production
- ·QC testing and releasing
- ·Worldwide distribution
Serum Life Sciences Europe →
- ·Clinical Trial management
- ·Translational project management
Serum Life Sciences UK →
- ·UK Corporate Office
Our worldwide network of facilities and partnerships
Serum Institute of India →
- ·Vaccine R&D
- ·Vaccine production
- ·Worldwide distribution
Bilthoven Biologicals →
- ·Vaccine production
- ·QC testing and releasing
- ·Worldwide distribution
Serum Life Sciences Europe →
- ·Clinical Trial management
- ·Translational project management
Serum Life Sciences UK →
- ·UK Corporate Office
Our worldwide network of facilities and partnerships
Serum Institute of India →
- ·Vaccine R&D
- ·Vaccine production
- ·Worldwide distribution
Bilthoven Biologicals →
- ·Vaccine production
- ·QC testing and releasing
- ·Worldwide distribution
Serum Life Sciences Europe →
- ·Clinical Trial management
- ·Translational project management
Serum Life Sciences UK →
- ·UK Corporate Office
Join our mission!
We believe in a world where protection is not a privilege, but a given. Are you interested in helping us achieve that goal?